GHK-Cu
Copper Peptide / GHK-Copper / Copper Tripeptide-1
GHK-Cu (Copper Peptide, Glycyl-L-Histidyl-L-Lysine:Copper(II)) is a naturally occurring tripeptide-copper complex found in human plasma, saliva, and urine that declines significantly with age. First identified by Dr. Loren Pickart in 1973 from human albumin, it functions as a potent wound healing, anti-inflammatory, and tissue remodeling signal with demonstrated effects on gene expression affecting over 4,000 human genes. It is researched both as an injectable peptide and as a topical cosmeceutical ingredient for skin rejuvenation, hair growth, and collagen synthesis.
작용 메커니즘
Naturally occurring copper-binding tripeptide (Gly-His-Lys) complexed with copper(II). Activates tissue remodeling genes, promotes collagen synthesis, increases decorin and glycosaminoglycan production, and recruits stem cells to injury sites. Also suppresses TGF-beta to reduce scarring.
연구 프로토콜
연구 용도만 사용 가능. 의학적 조언은 아닙니다.
Topical: 1-2% concentration applied twice daily. Subcutaneous: 50-200mcg daily near target area. Research cycles of 4-8 weeks for injectable use. Topical use is ongoing.
연구 노트
Clinical Research Status
GHK-Cu has extensive in vitro and animal research spanning over 50 years, with numerous published studies on wound healing, skin remodeling, and gene expression modulation. Multiple topical formulations containing GHK-Cu are commercially available as cosmeceuticals, though injectable forms remain investigational. No FDA-approved drug product exists, but the compound has GRAS (Generally Recognized as Safe) status in topical applications.
Key Published Findings
Gene expression studies (Broad Institute Connectivity Map) demonstrate that GHK-Cu resets approximately 32% of human genes toward a pattern associated with younger tissue, including upregulation of collagen, decorin, and tissue inhibitors of metalloproteinases. Research shows it stimulates production of glycosaminoglycans, promotes angiogenesis, and recruits immune cells to wound sites. Published data confirm it increases fibroblast proliferation, collagen synthesis by up to 70%, and significantly accelerates wound contraction in animal models.
Safety Profile
GHK-Cu has an excellent safety profile in both topical and injectable applications, with no significant adverse effects reported in published literature. Plasma GHK levels in healthy young adults are approximately 200ng/mL, declining to ~80ng/mL by age 60, suggesting physiological familiarity. Topical concentrations of 1-4% are well-tolerated without irritation, and injectable doses used in research (1-5mg daily) have not produced notable adverse events.
Drug Interactions & Contraindications
Theoretical concern exists with Wilson's disease (copper storage disorder) or other conditions of copper overload, as the peptide delivers bioavailable copper. May interfere with copper chelation therapy (penicillamine, trientine). No significant drug interactions have been documented, though concurrent use with other copper supplements should be monitored.
Comparison to Related Compounds
Unlike synthetic growth factors (EGF, FGF) which target single pathways, GHK-Cu acts as a broad-spectrum tissue remodeling signal affecting thousands of genes simultaneously. Compared to retinoids for skin anti-aging, GHK-Cu produces collagen stimulation without the irritation, dryness, or photosensitivity. AHK-Cu (Alanyl-Histidyl-Lysine:Copper) is a related analog with similar but less-studied properties.
Community Observations
Injectable research protocols typically use 1-5mg subcutaneously daily or several times per week, often combined with BPC-157 or TB-500 for systemic tissue repair. Topical application (cream, serum) at 1-3% concentration is popular for facial rejuvenation, hair thinning, and scar reduction with visible results typically reported at 4-8 weeks. The peptide is notable for its dual utility as both an injectable research compound and a commercially available topical with legitimate cosmetic efficacy.
반감기
~30-60 minutes
재조성
Bacteriostatic water (BAC) for injection; aqueous solution for topical
보관
건조한 상태
Refrigerate 2-8C up to 24 months.
재조성된 상태
Refrigerate 2-8C. Use within 21 days.
미국 법적 상태
또는 알려진 이름으로
자주 묻는 질문
GHK-Cu란 무엇인가요?
GHK-Cu (Copper Peptide, Glycyl-L-Histidyl-L-Lysine:Copper(II)) is a naturally occurring tripeptide-copper complex found in human plasma, saliva, and urine that declines significantly with age. First identified by Dr. Loren Pickart in 1973 from human albumin, it functions as a potent wound healing, anti-inflammatory, and tissue remodeling signal with demonstrated effects on gene expression affecting over 4,000 human genes. It is researched both as an injectable peptide and as a topical cosmeceutical ingredient for skin rejuvenation, hair growth, and collagen synthesis.
GHK-Cu는 어떻게 작용하나요?
Naturally occurring copper-binding tripeptide (Gly-His-Lys) complexed with copper(II). Activates tissue remodeling genes, promotes collagen synthesis, increases decorin and glycosaminoglycan production, and recruits stem cells to injury sites. Also suppresses TGF-beta to reduce scarring.
GHK-Cu의 미국 규제 현황은 어떤가요?
Research chemical (injectable) / Cosmetic ingredient (topical)
GHK-Cu의 반감기는 얼마인가요?
~30-60 minutes
GHK-Cu의 다른 이름은 무엇인가요?
Copper Peptide, GHK-Copper, Copper Tripeptide-1
Peptide Contacts는 정보 제공을 위해 연구 기반 요약을 제공합니다. 우리는 공급업체 문서를 호스팅, 배포하거나 지지하지 않습니다. 모든 테스트 보고서, GMP 인증서 및 공급업체 통신은 구매자는 직접 요청하고 확인해야 합니다. 이 플랫폼에서 제공되는 어떠한 정보도 법적, 의학적 또는 전문적인 조언을 대체하지 않습니다. 사용자는 모든 관련 지역법, 주법 및 연방법에 부합하기 위해 공급업체 자격 증명을 검증하고 구매하기 전에 준수해야 합니다. 이 플랫폼의 사용은 이러한 책임을 완전히 지닌 것으로 간주됩니다.
전체 공지사항 읽기